Home NDC 52959-994 TOPIRAMATE
Product NDC 52959-994
11-digit product format 529590994
Labeler code 52959
Product ID 52959-994_7e3a6da2-f432-4a62-ab53-c305587b7726
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name topiramate
Dosage form TABLET
Route ORAL
Labeler H.J. Harkins Company, Inc.
Application ANDA079153
Marketing category ANDA
Marketing start 2009-03-27
Marketing end 0000-00-00
Substance TOPIRAMATE
Active strength 50 mg/1
Pharmacologic classes Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C19 Inhibitors [MoA]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 2 · 110 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A079153-001 TOPIRAMATE TOPIRAMATE 25MG TABLET / ORAL 2009-03-27 A079153-002 TOPIRAMATE TOPIRAMATE 50MG TABLET / ORAL 2009-03-27 A079153-003 TOPIRAMATE TOPIRAMATE 100MG TABLET / ORAL 2009-03-27 A079153-004 TOPIRAMATE TOPIRAMATE 200MG TABLET / ORAL 2009-03-27
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A079153-001 TOPIRAMATE 25MG TABLET / ORAL 2009-03-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A079153-002 TOPIRAMATE 50MG TABLET / ORAL 2009-03-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A079153-003 TOPIRAMATE 100MG TABLET / ORAL 2009-03-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A079153-004 TOPIRAMATE 200MG TABLET / ORAL 2009-03-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A079153-001 TOPIRAMATE 25MG TABLET / ORAL 2009-03-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A079153-002 TOPIRAMATE 50MG TABLET / ORAL 2009-03-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A079153-003 TOPIRAMATE 100MG TABLET / ORAL 2009-03-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A079153-004 TOPIRAMATE 200MG TABLET / ORAL 2009-03-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A079153-001 TOPIRAMATE 25MG TABLET / ORAL 2009-03-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A079153-002 TOPIRAMATE 50MG TABLET / ORAL 2009-03-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A079153-003 TOPIRAMATE 100MG TABLET / ORAL 2009-03-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A079153-004 TOPIRAMATE 200MG TABLET / ORAL 2009-03-27 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A079153-001 TOPIRAMATE 25MG TABLET / ORAL 2009-03-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A079153-002 TOPIRAMATE 50MG TABLET / ORAL 2009-03-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A079153-003 TOPIRAMATE 100MG TABLET / ORAL 2009-03-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A079153-004 TOPIRAMATE 200MG TABLET / ORAL 2009-03-27 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A079153-001 TOPIRAMATE 25MG TABLET / ORAL 2009-03-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A079153-002 TOPIRAMATE 50MG TABLET / ORAL 2009-03-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A079153-003 TOPIRAMATE 100MG TABLET / ORAL 2009-03-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A079153-004 TOPIRAMATE 200MG TABLET / ORAL 2009-03-27 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A079153-001 TOPIRAMATE 25MG TABLET / ORAL 2009-03-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A079153-002 TOPIRAMATE 50MG TABLET / ORAL 2009-03-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A079153-003 TOPIRAMATE 100MG TABLET / ORAL 2009-03-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A079153-004 TOPIRAMATE 200MG TABLET / ORAL 2009-03-27 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A079153-001 TOPIRAMATE 25MG TABLET / ORAL 2009-03-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A079153-002 TOPIRAMATE 50MG TABLET / ORAL 2009-03-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A079153-003 TOPIRAMATE 100MG TABLET / ORAL 2009-03-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A079153-004 TOPIRAMATE 200MG TABLET / ORAL 2009-03-27 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A079153-001 TOPIRAMATE 25MG TABLET / ORAL 2009-03-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A079153-002 TOPIRAMATE 50MG TABLET / ORAL 2009-03-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A079153-003 TOPIRAMATE 100MG TABLET / ORAL 2009-03-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A079153-004 TOPIRAMATE 200MG TABLET / ORAL 2009-03-27 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A079153-001 TOPIRAMATE 25MG TABLET / ORAL 2009-03-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A079153-002 TOPIRAMATE 50MG TABLET / ORAL 2009-03-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A079153-003 TOPIRAMATE 100MG TABLET / ORAL 2009-03-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A079153-004 TOPIRAMATE 200MG TABLET / ORAL 2009-03-27 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A079153-001 TOPIRAMATE 25MG TABLET / ORAL 2009-03-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A079153-002 TOPIRAMATE 50MG TABLET / ORAL 2009-03-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A079153-003 TOPIRAMATE 100MG TABLET / ORAL 2009-03-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A079153-004 TOPIRAMATE 200MG TABLET / ORAL 2009-03-27 d06236e962d9…
Observed Orange Book normalized TE history# DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 52959-994-02 TOPIRAMATE 120 in 1 BOTTLE TABLET 120 3 52959-994-30 TOPIRAMATE 30 in 1 BOTTLE TABLET 30 3 52959-994-60 TOPIRAMATE 60 in 1 BOTTLE TABLET 60 3 52959-994-90 TOPIRAMATE 90 in 1 BOTTLE TABLET 90 3
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded TOPIRAMATE ACTIVE INGREDIENT 0H73WJJ391 TOPIRAMATE ( TOPIRAMATE ) TABLET [H.J. HARKINS COMPANY, INC.] 3 TOPIRAMATE ACTIVE MOIETY 0H73WJJ391 TOPIRAMATE ( TOPIRAMATE ) TABLET [H.J. HARKINS COMPANY, INC.] 3 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U TOPIRAMATE ( TOPIRAMATE ) TABLET [H.J. HARKINS COMPANY, INC.] 3 COLLOIDAL SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 TOPIRAMATE ( TOPIRAMATE ) TABLET [H.J. HARKINS COMPANY, INC.] 3 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT TOPIRAMATE ( TOPIRAMATE ) TABLET [H.J. HARKINS COMPANY, INC.] 3 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO TOPIRAMATE ( TOPIRAMATE ) TABLET [H.J. HARKINS COMPANY, INC.] 3 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X TOPIRAMATE ( TOPIRAMATE ) TABLET [H.J. HARKINS COMPANY, INC.] 3 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 TOPIRAMATE ( TOPIRAMATE ) TABLET [H.J. HARKINS COMPANY, INC.] 3 POLYETHYLENE GLYCOL 400 INACTIVE INGREDIENT B697894SGQ TOPIRAMATE ( TOPIRAMATE ) TABLET [H.J. HARKINS COMPANY, INC.] 3 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 TOPIRAMATE ( TOPIRAMATE ) TABLET [H.J. HARKINS COMPANY, INC.] 3 TALC INACTIVE INGREDIENT 7SEV7J4R1U TOPIRAMATE ( TOPIRAMATE ) TABLET [H.J. HARKINS COMPANY, INC.] 3 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP TOPIRAMATE ( TOPIRAMATE ) TABLET [H.J. HARKINS COMPANY, INC.] 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 52959-994 TOPIRAMATE ( TOPIRAMATE ) TABLET [H.J. HARKINS COMPANY, INC.] 3 Legacy NDC, 4 package rows 20120120_546130a3-e5f2-422d-88f0-66de19540ecb.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Status 52959-994-02 52959099402 120 in 1 BOTTLE Historical 52959-994-30 52959099430 30 in 1 BOTTLE Historical 52959-994-60 52959099460 60 in 1 BOTTLE Historical 52959-994-90 52959099490 90 in 1 BOTTLE Historical